famciclovir vs raloxifene
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of famciclovir and raloxifene. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Raloxifene, a potent aldehyde oxidase inhibitor in vitro, could decrease the formation of penciclovir. However, a clinical drug-drug interaction study to determine the magnitude of interaction between penciclovir and raloxifene has not been conducted.
Famvir
Evista
Famciclovir is an antiviral medicine. It helps to treat infections caused by certain viruses.
Raloxifene (Evista) is a medicine that can help treat and prevent bone loss (osteoporosis) in women after menopause. It can also lower the chance of getting a certain type of breast cancer.
This medicine treats herpes infections. It can treat cold sores, genital herpes, and shingles. It can also prevent genital herpes outbreaks. This medicine may not work for everyone, including first-time genital herpes, eye shingles, or certain immunocompromised patients.
This medicine is used to treat and prevent osteoporosis in women after menopause. It can also lower the risk of invasive breast cancer in women after menopause who have osteoporosis or are at high risk of getting it. This medicine is not for treating breast cancer, lowering the risk of breast cancer coming back, or lowering the risk of non-invasive breast cancer.
Famciclovir stops the virus from multiplying. It does this by blocking a key enzyme the virus needs to make copies of itself. This helps your body fight off the infection.
Raloxifene belongs to a class of drugs called Selective Estrogen Receptor Modulators (SERMs). It works like estrogen in some parts of the body, such as bones, which helps to prevent bone loss. But it blocks estrogen's effects in other parts of the body, like the breast, which can help prevent certain types of breast cancer.
- • Headache
- • Nausea
- • Hot flashes
- • Leg cramps
- • Swelling in your legs or feet
- • Flu-like symptoms
- • Joint pain
- Fatigue 185
- Diarrhoea 179
- Nausea 145
- Headache 135
- Pain 118
- Fatigue 143
- Arthralgia 109
- Diarrhoea 109
- Fall 107
- Nausea 106
If you have kidney problems, make sure your doctor knows. Taking too much famciclovir when you have kidney problems can damage your kidneys.
Raloxifene can increase your risk of blood clots in your veins (deep vein thrombosis) and lungs (pulmonary embolism). If you have had blood clots in the past, you should not take this medicine. Raloxifene can also increase the risk of death from stroke in women who have heart disease or are at risk for heart problems. Talk to your doctor about the risks and benefits of taking raloxifene if you are at risk for stroke.
Tell your doctor if you are pregnant or plan to become pregnant. Untreated herpes during pregnancy can harm the baby. It is not known if famciclovir passes into breast milk.
You should not take this medicine if you are pregnant or could become pregnant. It may harm your unborn baby. Do not use this medicine if you are breastfeeding.
Also Compare, Nearby Drugs
Compare famciclovir with
Compare raloxifene with
How to Read This famciclovir vs raloxifene Comparison
famciclovir is classified in the Antiviral (Nucleoside Analog) drug class, while raloxifene sits within the Selective Estrogen Receptor Modulator (SERM) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, famciclovir has 762 submissions while raloxifene has 574. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to raloxifene may block the enzyme needed to turn famciclovir into its active form, which could make the drug less effective.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for famciclovir or raloxifene.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.